Dr. Mrinalini Dey of London was invited to present her research at the 2023 Rheumatology Research Workshop in Orlando. She describes the experience here.
Editor Keri Losavio has been a professional editor and writer in the medical and financial fields for 20 years and joined the Wiley team in February 2014. She has written for and edited newsletters, magazines, personal memoirs, book proposals, dissertations, textbooks and more.
Articles by Keri Losavio
Interferons in Systemic Lupus Erythematosus
Current knowledge of receptor-ligand interactions, cell signaling, and transcriptional regulation derive from studies of type I interferon. The design of novel therapeutics is informed by the advances in investigation of type I interferon, with the potential for important impacts on patient management.
In Memoriam … Debashish Danda, MBBS, MD, DM, FRCP (1958–2024)
Dedicated to advancing rheumatology education worldwide On Feb. 2, 2024, distinguished professor of medicine and rheumatology Debashish Danda, MBBS, MD, DM, FRCP, was lost to the world following a tragic motor vehicle accident. Dr. Danda was highly respected both in his home country of India and on the international stage for his contributions to advancing…
The Roles of the Interdisciplinary Rheumatology Team in Patient Care Highlighted
To work together effectively, clinicians and rheumatology professionals need to understand the roles of every member of the interdisciplinary team. To enhance this understanding, the ARP Interprofessional Practice & Management Committee has undertaken a project to describe the modern roles of members of the interdisciplinary team in a series of fact sheets. The first three…
In Memoriam … Robert James Lloyd Jr., MD, FACP, MACR (1943–2024)
A journey of excellence by a quintessential rheumatologist Robert James Lloyd Jr., MD, FACP, MACR, passed away peacefully on Feb. 4, 2024, at his home in Falls Church, Va. Bob, as he was known to loved ones, was born in Washington, D.C., on Jan. 6, 1943. He grew up in Providence, R.I., where he attended…
No Pain, Much to Gain
SAN DIEGO—Pain is one of the most common symptoms of rheumatic disease, and this session at ACR Convergence 2023 was dedicated to understanding recent research concerning the relationship between pain and inflammation.
Large Vessel Vasculitis
SAN DIEGO—The large vessel vasculitides, including Takayasu’s arteritis and giant cell arteritis, experienced a surge of interest at ACR Convergence 2023. Here, we highlight important points from 10 of the studies presented at this conference.
Top Research in ANCA-Associated Vasculitis Presented at ACR Convergence 2023
SAN DIEGO—Vasculitis expert and former editor of The Rheumatologist, Dr. Philip Seo gives us his picks for the 10 most important abstracts in ANCA-associated vasculitis to come out of ACR Convergence 2023.
The Heterogeneity of Psoriatic Arthritis
SAN DIEGO—Differences between psoriatic arthritis and rheumatoid arthritis highlight the need for the development of imaging modalities, laboratory tests and other biomarkers that are explored and validated specifically for PsA to advance the goal of personalized or precision medicine. In this article, expert David S. Pisetsky, MD, PhD, explores the top research in psoriatic arthritis presented at ACR Convergence 2023.
Life with Arthritis: Kaleb Michaud, PhD, Shares His Story
SAN DIEGO—“I’m going to get personal,” said Kaleb Michaud, PhD, in the ARP Distinguished Lecture at ACR Convergence 2023. When he was 3 years old, the young Kaleb was diagnosed him with juvenile rheumatoid arthritis (JRA).
- 1
- 2
- 3
- …
- 12
- Next Page »